Market Overview

Cantor Fitzgerald Reiterates Hold Rating, $29 PT for Centene

Share:
Related CNC
Earnings Scheduled For July 28, 2015
UBS Has Had Enough: Centene Upgraded To Buy On 'Underappreciated Opportunities'
Molina Healthcare Beats Q2 Earnings on Membership Growth - Analyst Blog (Zacks)

In a report published earlier today, Cantor Fitzgerald L.P. reiterated its Hold rating and $29.00 price target for Centene Corp. (NYSE: CNC).

Cantor Fitzgerald went on to say “Centene's earnings shortfall is a big psychological blow to the Medicaid names, which have surged on the expectation that the increased application of managed care to complex cases will boost the sector's business, but earnings have lagged. This raises concern about its ability to capitalize on the industry's growth in other new and larger markets.”

Centene Corp. closed yesterday at $28.20.

Latest Ratings for CNC

DateFirmActionFromTo
Jul 2015UBSUpgradesNeutralBuy
Jul 2015Goldman SachsDowngradesNeutralSell
Jul 2015JefferiesUpgradesHoldBuy

View More Analyst Ratings for CNC
View the Latest Analyst Ratings

Posted-In: Cantor FitzgeraldAnalyst Color Reiteration Analyst Ratings

 

Related Articles (CNC)

Get Benzinga's Newsletters